www.taro.com

Trademarks and Copyright© The images and information contained in the Site are, to the fullest extent possible, copyrighted and otherwise proprietary. It is the policy of Taro to enforce its intellectual property rights to the fullest extent of the law, including (where applicable) seeking criminal sanctions.

News Release

 << Back



Taro to Announce Full Year Results on May 26, 2022

PDF Version

HAWTHORNE, N.Y.--(BUSINESS WIRE)--May 20, 2022-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the year ended March 31, 2022, after the close of market on Thursday, May 26, 2022.

The release will be accessible on Taro’s website at www.taro.com.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

William J. Coote
VP, Chief Financial Officer
(914) 345-9001
William.Coote@taro.com

Source: Taro Pharmaceutical Industries Ltd.

Terms of Use		 |
Privacy Statement		 |
Safe Harbor Statement